Table 1.
Diet composition, as fed.
Table 2.
Growth performance parameters of pigs in either control (CON) or sub-therapeutic chlortetracycline (sCTC; 40 ppm) treatments.
Table 3.
Ex vivo markers of intestinal permeability and nutrient uptake of pigs in either control (CON) or sub-therapeutic chlortetracycline (sCTC; 40 ppm) treatments.
Table 4.
Cecal short chain fatty acid concentrations (mM/g cecal content) of pigs in either control (CON) or sub-therapeutic chlortetracycline (sCTC; 40 ppm) treatments.
Table 5.
Gene abundance in the ileum of pigs in either control (CON) or sub-therapeutic chlortetracycline (sCTC; 40 ppm) treatments.
Fig 1.
Pairwise proteome comparisons in the A) ileum, B) colon, C) longissimus muscle (LM), and D) liver of pigs in control (CON) and sub-therapeutic chlortetracycline (sCTC; 40 ppm) treatments. Proteins identified are demonstrated in relation to average ion intensity differences and P-value (statistical significance).
Fig 2.
Biological processes of differentially abundant proteins in in the A) ileum, B) colon, C) longissimus muscle, and D) liver of pigs in sub-therapeutic chlortetracycline (sCTC; 40 ppm) compared with control (CON) treatments.
Table 6.
Significantly different protein abundances in the ileum, colon, longissimus muscle, and liver of pigs in either control (CON) or sub-therapeutic chlortetracycline (sCTC; 40 ppm) treatments.